Update on CTEPH

Apr 14, 2022 | PAH

1) Welcome to a new #accredited #tweetorial about an important complication of #pulmonaryembolism (#PE): chronic thromboembolic pulmonary hypertension #CTEPH. Follow this thread to earn 0.75h CE/#CME #physicians #physicianassociates #NPs #nurses #pharmacists. 2) I am...

The role of elevated LDL-C levels in the pathogenesis and pathophysiology of ASCVD

Apr 5, 2022 | LIPIDS

2) This #tweetorial, accredited for #CME/CE and intended for #physicians #physicianassociates #nurses #nursepractitioners #pharmacists is supported by an educational grant from Esperion Therapeutics. See faculty disclosures at https://t.co/gvXca4G9Xm.—...

Parenteral Antiplatelet Therapy in Neurovascular Interventions

Mar 29, 2022 | PLATELETS

1) Welcome to a new #accredited #tweetorial on parenteral #antiplatelet therapy in #neurovascular interventions. Our expert author is Fawaz Al-Mufti MD @almuftifawaz, interventional #neurologist Interventional Neurologist @nymedcollege @WestchesterMed @neurocritical...

The Mechanism of Action and Use of Ezetimibe and/or Bempedoic Acid in Lipid Management

Mar 22, 2022 | LIPIDS

1) Welcome to @cardiomet_CE's new series on #lipid management! This is a 10-#tweetorial program, all #accredited, that will cover it all. Our first expert author is Paul Thompson MD @PaulDThompsonMD, esteemed #cardiologist from @hartfordhosp @UConn Med & now...

NEW ADA-KDIGO CONSENSUS STATEMENT ON DKD

Mar 15, 2022 | CARDIORENAL

1) Welcome to a new #accredited #tweetorial from our good friends and #diabetes experts @GoggleDocs, specifically @drkevinfernando, @drpatrickholmes, & @AmarPut. They have put their 🗣️s together to provide us with a summary of the first-ever consensus statement...